Catalyst Funds Management’s HUTCHMED HCM Stock Holding History

Catalyst Funds Management’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-109,845	Closed	-$1.65M	–	571
2025 Q2	$1.65M	Sell	109,845 -29,903	-21%	-$437K	0.46%	59
2025 Q1	$2.1M	Sell	139,748 -2,483	-2%	-$36.7K	0.55%	48
2024 Q4	$2.05M	Hold	142,231	–	–	0.5%	43
2024 Q3	$2.78M	Hold	142,231	–	–	0.61%	21
2024 Q2	$2.43M	Hold	142,231	–	–	0.65%	25
2024 Q1	$2.39M	Buy	+142,231	New	+$2.16M	0.67%	44

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Catalyst Funds Management's HCM Position: Q3 2025 in Review

Catalyst Funds Management sold out of HUTCHMED (HCM) in Q3 2025, closing a stake of 109,845 shares — an estimated $1.65M sold.

Catalyst Funds Management first reported a position in HCM in Q1 2024 and held it in 6 quarters. The position peaked at $2.78M in Q3 2024. 58 funds tracked by Wall St. Rank hold HCM as of Q3 2025.

Catalyst Funds Management reported no remaining HUTCHMED position as of Q3 2025 after selling out during the quarter.
Catalyst Funds Management sold 109,845 HUTCHMED shares in Q3 2025, an estimated $1.65M.
Catalyst Funds Management first reported a position in HUTCHMED in Q1 2024 and held it in 6 quarters.
Catalyst Funds Management's HUTCHMED position peaked at $2.78M in Q3 2024.
58 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2025.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.